Literature DB >> 18064728

Hydrolysis of various bioactive peptides by goat brain dipeptidylpeptidase-III homologue.

Suman Dhanda1, Jasbir Singh, Hari Singh.   

Abstract

DPP-III from goat brain was purified to apparent electrophoretic homogeneity which showed several characteristics similar to other reported DPP-IIIs although it possesses dissimilar molecular weight and different inhibition behavior. Thin layer chromatographic studies with goat brain DPP-III revealed that it hydrolyses Leu-enkephalin (Tyr-Gly-Gly-Phe-Leu) at the Gly-Gly bond producing Tyr-Gly and Gly-Phe-Leu with no further degradation of liberated tripeptide. (Ala)(4) is hydrolyzed to dialanine whereas trialanine is not cleaved. ACTH, angiotensin II and III were also hydrolyzed whereas angiotensin I was not. It was concluded that the enzyme requires at least a tetrapeptide to act and that it removes a dipeptidyl moiety from the NH(2)-terminus of the studied peptides. Goat brain DPP-III may be involved in the metabolism of very important bioactive peptides such as enkephalins and angiotensins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18064728     DOI: 10.1002/cbf.1448

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  3 in total

1.  Activity Staining and Inhibition Characterization of Dipeptidylpeptidase-III Enzyme from Goat Brain.

Authors:  Pooja Attri; Jasbir Singh; Suman Dhanda; Hari Singh
Journal:  Enzyme Res       Date:  2011-04-11

2.  Purification, kinetic and functional characterization of membrane bound dipeptidyl peptidase-III from NCDC 252: a probiotic lactic acid bacteria.

Authors:  Pooja Attri; Drukshakshi Jodha; Jasbir Singh; Suman Dhanda
Journal:  Mol Biol Rep       Date:  2018-07-23       Impact factor: 2.316

3.  Substrate complexes of human dipeptidyl peptidase III reveal the mechanism of enzyme inhibition.

Authors:  Prashant Kumar; Viktoria Reithofer; Manuel Reisinger; Silvia Wallner; Tea Pavkov-Keller; Peter Macheroux; Karl Gruber
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.